Seek Returns

ELAN vs. GSK: Elanco Animal Health vs. GSK Stock Comparison

How do Elanco Animal Health (ELAN) and GSK (GSK) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Elanco Animal Health (ELAN) and GSK (GSK) are both classified in the Pharmaceuticals sub-industry within the broader Pharmaceuticals industry, placing them in the closest GICS peer bucket.

Elanco Animal Health (ELAN) trades as ordinary local shares, while GSK (GSK) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for Elanco Animal Health (ELAN) and GSK (GSK)
Profile ItemELANGSK
NameElanco Animal Health IncorporatedGSK plc ADR
Country/RegionUnited StatesUnited Kingdom
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticalsPharmaceuticals
GICS Sub-IndustryPharmaceuticalsPharmaceuticals
Market Capitalization12.86 billion USD100.88 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateSeptember 20, 2018March 28, 1980
Security TypeCommon StockADR

Price Performance

Cumulative Growth

ELAN
GSK
GSPC
Loading price history…
Elanco Animal Health (ELAN) vs. GSK (GSK), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Elanco Animal Health (ELAN) and GSK (GSK). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Elanco Animal Health (ELAN) and GSK (GSK). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
Total Return (1Y)24.03%13.73%
Total Return (3Y, Annualized)37.47%18.65%
Total Return (5Y, Annualized)-4.24%7.97%

Risk Profile

Drawdown History

ELAN
GSK
GSPC
Loading price history…
Elanco Animal Health (ELAN) vs. GSK (GSK), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Elanco Animal Health (ELAN) and GSK (GSK). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Elanco Animal Health (ELAN) has an aggressive beta of 1.65, indicating higher sensitivity to broad-market moves, while GSK (GSK) is defensive at 0.31 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
Volatility (1Y, Annualized)43.57%26.25%
Beta (5Y)1.650.31
Max Drawdown (5Y)-75.59%-37.63%
Avg. Volume (3M)5.65M4.05M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ELAN and GSK are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
Sharpe Ratio (1Y)0.450.36
Sortino Ratio (1Y)0.660.56

Profitability

ROE (TTM)

Capital efficiency shows on one side only: GSK (GSK) earns 28.27% on shareholders’ equity, ranked against its industry; Elanco Animal Health (ELAN) has no ROE this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ELAN
--

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

28.27%

Max
109.18%
GSK
28.27%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): ELAN does not report ROE, so it has no value marker; GSK is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile GSK (GSK) reports 12.97%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

12.97%

Max
18.05%
GSK
12.97%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

GSK (GSK) at 32.14% operates in the top operating margin quartile, ahead of Elanco Animal Health (ELAN) at 6.64%, which runs around its industry’s norm.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max
83.12%
Q3
14.77%
ELAN
6.64%
Median
0.00%
Q1
-78.82%
Min
-207.40%

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

32.14%

Max
83.12%
GSK
32.14%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
ROE (TTM)--28.27%
ROA (TTM)--9.24%
Net Margin (TTM)-2.86%12.97%
Operating Margin (TTM)6.64%32.14%
Gross Margin (TTM)56.18%73.79%

Growth

Revenue Growth

Both Elanco Animal Health (ELAN) at 6.22% and GSK (GSK) at 4.11% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their Revenue Growth across different time periods.

EPS Growth

GSK (GSK) at 123.15% sits in the top EPS growth quartile, while Elanco Animal Health (ELAN) at -169.12% is in the bottom quartile, showing a clear gap in earnings momentum.

Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
Revenue Growth (YoY)6.22%4.11%
Revenue Growth (3Y CAGR)2.25%3.66%
EPS Growth (YoY)-169.12%123.15%
EPS Growth (3Y CAGR)---27.63%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: GSK (GSK) shows current ratio of 0.86 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ELAN
--

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.86

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
GSK
0.86
Min
0.10
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): ELAN does not report current ratio, so it has no value marker; GSK is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Elanco Animal Health (ELAN) at 0.64 carries an industry-typical debt-to-equity mix, while GSK (GSK) at 1.30 uses more debt funding than most peers.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max
1.42
Q3
0.65
ELAN
0.64
Median
0.15
Q1
0.02
Min
0.00

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.30

Max
1.42
GSK
1.30
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
Current Ratio (MRQ)--0.86
Debt / Equity (MRQ)0.641.30
Net Debt / EBITDA3.491.88

Dividends

Dividend Yield (TTM)

Elanco Animal Health (ELAN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GSK (GSK) reports a yield of 1.57%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.57%

GSK
1.57%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Elanco Animal Health (ELAN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GSK (GSK) reports a payout of 63.33%, ranking against industry peers normally.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

63.33%

GSK
63.33%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
Dividend Yield (TTM)0.00%1.57%
Dividend Payout Ratio (TTM)0.00%63.33%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: GSK (GSK) trades at 17.54 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

17.54

Max
85.34
Q3
43.46
Median
26.69
GSK
17.54
Q1
13.30
Min
0.07
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): ELAN does not report P/E ratio, so it has no value marker; GSK is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Both Elanco Animal Health (ELAN) at 2.50 and GSK (GSK) at 3.01 fetch a relatively low price per dollar of sales, landing in the cheaper P/S ratio quartile of their industries.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.50
Min
0.01

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.01

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
GSK
3.01
Min
0.01
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Elanco Animal Health (ELAN) at 1.95 and GSK (GSK) at 4.02 are valued close to their industries’ norm against book — neither stands out from peers.

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
13.53
Q3
6.54
Median
3.25
ELAN
1.95
Q1
1.69
Min
-5.59

GSK

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.02

Max
13.53
Q3
6.54
GSK
4.02
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
Elanco Animal Health (ELAN) vs. GSK (GSK): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Elanco Animal Health (ELAN) and GSK (GSK)
MetricELANGSK
P/E Ratio (TTM)--17.54
P/S Ratio (TTM)2.503.01
P/B Ratio (MRQ)1.954.02
Free Cash Flow Yield (TTM)--5.28%